NCT07423091Not yet recruiting
Exergame-Based Upper-Limb Rehabilitation in Adults With Chronic Stroke
A Randomized Controlled Trial Assessing the Efficacy, Feasibility, and Usability of an Exergame-Based Semi-Autonomous Upper-Limb Rehabilitation Program in Individuals With Chronic Stroke
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
This study is a randomized controlled trial designed to evaluate the effectiveness of a semi-autonomous upper-limb rehabilitation program based on exergames in adults with chronic stroke. Participants will be randomly assigned (1:1) to either an exergame-based intervention or an individually delivered conventional home-based therapy program. The primary outcome is upper-limb functionality as measured by the Action Research Arm Test (ARAT). Secondary outcomes include upper-limb motor function and quality of life. The study also examines adherence, usability, and the feasibility of remote monitoring for long-term implementation.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 11 Feb 2026
- Start date
- Apr 2026
- Primary completion date
- Oct 2026
- Lead sponsor
- Marina Castel Sánchez
- Diseases
- Stroke
- NCT number
- NCT07423091
What you commit to
- Study type: Interventional
- Planned participants: 32
- From Apr 2026 to the primary completion date, Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Botulinum toxin treatment affecting the upper limb within the previous 6 months.
Other illness
- Acute illness, musculoskeletal pathology, or pain that interferes with the performance of rehabilitation exercises.
- Disruptive behavior or neuropsychiatric conditions that may limit participation.
- Active epilepsy or any medical contraindication to physical exercise.
Other
- Uncompensated sensory deficits, including significant visual or hearing impairments.
Who the study is looking for
- Adults aged 18 years or older.
- Confirmed diagnosis of chronic stroke with more than 6 months of evolution.
- Ability to maintain independent sitting and standing (with or without assistive devices).
- Upper-limb functional capacity ranging from limited to moderate, defined as an ARAT score between 11 and 54 points.
- Ability to understand and follow simple instructions (Mini-Mental State Examination ≥ 23).
- Ability to provide informed consent personally or through a legal representative.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.